ClinicalTrials.Veeva

Menu

Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection

George Washington University (GW) logo

George Washington University (GW)

Status

Completed

Conditions

HIV
HIV Infections

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection. Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent amplification or the Cepheid Xpert HIV-1 Quant Assay. A false negative or false positive rate of >1.0% would make this test unacceptable as a screening test for HIV viremia.

Enrollment

153 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Current patient in the Medical Faculty Associates Infectious Diseases (ID) clinic with known HIV infection
  • Suspected to be viremic at the time of their clinic visit based on history and/or current symptoms
  • Able to provide informed consent
  • 18 Years or older

Exclusion criteria

  • Patient unable to provide informed consent.
  • Pregnancy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems